Zura Bio Ltd. Announces Director and Officer Changes
Ticker: ZURA · Form: 8-K · Filed: Oct 10, 2025 · CIK: 1855644
| Field | Detail |
|---|---|
| Company | Zura Bio Ltd (ZURA) |
| Form Type | 8-K |
| Filed Date | Oct 10, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
Related Tickers: ZURA
TL;DR
Zura Bio (ZURA) board shakeup announced, new directors and officers elected.
AI Summary
Zura Bio Ltd. announced on October 8, 2025, changes related to its board of directors and officers, including the election of new directors and the appointment of certain officers. The company, formerly known as JATT Acquisition Corp, is incorporated in the Cayman Islands and operates in the biological products sector.
Why It Matters
Changes in a company's board and executive team can signal shifts in strategy, governance, or operational focus, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing reports routine corporate governance changes, such as director and officer appointments, which typically carry low immediate risk.
Key Players & Entities
- Zura Bio Ltd (company) — Registrant
- JATT Acquisition Corp (company) — Former Company Name
- Cayman Islands (jurisdiction) — Place of Incorporation
- October 8, 2025 (date) — Date of Earliest Event Reported
FAQ
What specific items are being reported under the 8-K filing?
The filing reports on the Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; and Compensatory Arrangements of Certain Officers.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on October 8, 2025.
What is Zura Bio Ltd.'s former company name?
Zura Bio Ltd.'s former company name was JATT Acquisition Corp.
In which jurisdiction is Zura Bio Ltd. incorporated?
Zura Bio Ltd. is incorporated in the Cayman Islands.
What is the Standard Industrial Classification (SIC) code for Zura Bio Ltd.?
The SIC code for Zura Bio Ltd. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 557 words · 2 min read · ~2 pages · Grade level 13.1 · Accepted 2025-10-10 08:20:32
Key Financial Figures
- $0.0001 — ed Class A Ordinary Shares, par value $0.0001 per share ZURA The Nasdaq Stock Mar
Filing Documents
- tm2528470d1_8k.htm (8-K) — 27KB
- 0001104659-25-098546.txt ( ) — 190KB
- zura-20251008.xsd (EX-101.SCH) — 3KB
- zura-20251008_lab.xml (EX-101.LAB) — 33KB
- zura-20251008_pre.xml (EX-101.PRE) — 22KB
- tm2528470d1_8k_htm.xml (XML) — 4KB
02 Departure of Directors or Certain
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 8, 2025, Robert Lisicki, Chief Executive Officer (principal executive officer) and member of the Board of Directors of Zura Bio Limited (the "Company") informed the Company that he is taking a medical leave of absence, effective October 10, 2025. Accordingly, effective October 10, 2025, the Company's Board of Directors appointed Kim Davis, Chief Operating Officer, Chief Legal Officer and Corporate Secretary, to serve as the Company's interim Chief Executive Officer and interim principal executive officer, in addition to her current duties. Biographical and other information for Ms. Davis is set forth in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 23, 2025 and is incorporated herein by reference. Ms. Davis is not party to any arrangement or understanding pursuant to which she was appointed as an officer, nor is she party to any transactions required to be disclosed pursuant to Item 404(a) of Regulation S-K. There are no family relationships between Ms. Davis and any of the Company's directors or executive officers.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZURA BIO LIMITED Date: October 10, 2025 By: /s/ Kim Davis Kim Davis Interim Chief Executive Officer, Chief Operating Officer, Chief Legal Officer and Corporate Secretary